CACC
Credit Acceptance Corp
NASDAQ · Financial Services
$508.90
+13.83 (+2.79%)
CACC News4 articles
AbbVie Gains on Moody's Credit Upgrade, Focus Shifts to Immunology Portfolio
AbbVie shares rose 2% to $223.43 after Moody's upgraded its credit rating to A2 with a stable outlook. Investors now watch demand and pricing for Skyrizi and Rinvoq amid Humira competition.
NXP Secures $3B Credit Facility as Chip Sector Rallies on AI Spending
NXP Semiconductors amended a $3 billion revolving credit line with Barclays, maturing in 2031, while the broader chip sector surged on AI investment signals from major tech firms.
AbbVie Shares Gain 2% to Close Near $223 Amid Earnings Volatility, Credit Upgrade
AbbVie stock rose 2% Friday, ending a turbulent week marked by earnings scrutiny and a Moody's credit rating upgrade. Investors remain focused on Skyrizi and Rinvoq growth amid competitive pressures.
SK Hynix Shares Dip Amid Tech Sell-Off Despite S&P Credit Upgrade
SK Hynix shares declined 0.36% to 839,000 won on Friday, extending a weekly loss of 8% as Asian tech stocks retreated, even after S&P upgraded its credit rating to BBB+ with a positive outlook.